Tedatioxetine, formerly known as Lu AA24530, is an antidepressant agent. Tedatioxetine is reported to act as a triple reuptake inhibitor (5-HT > NE > DA) and 5-HT2A, 5-HT2C, 5-HT3 and α1A-adrenergic receptor antagonist. As of 2009, it was in phase II clinical trials for major depressive disorder. References: Javelot H. [Psychopharmacology of anxiety and depression: Historical aspects, current treatments and perspectives]. Ann Pharm Fr. 2015 Oct 12. pii: S0003-4509(15)00110-8. doi: 10.1016/j.pharma.2015.09.001. [Epub ahead of print] Review. French. PubMed PMID: 26472602.

纯度：≥98%

CAS：508233-95-2